This is the problem with the lodged prospectus. No mention of...

This is the problem with the lodged prospectus. No mention of new patients, no mention of hospitals and no mention of forward looking revenue. Under the assumption we turn over $25m USD we are fair value at $6 a share. However with $8m USD in revenue we are significantly overpriced as pointed out by seeking alpha...

However if they can pull off the $6 IPO and then release those details this could go up very quickly...